semaglutide discontinued US, Japan Patients With Diabetes Discontinue After First Year Weight Watchers discontinued compound semaglutide.

[2] From a pharmacological perspective, the mechanisms of action of these medications operate through different pathways and do not directly interfere with one another

Some of them work remarkably well

It's important to note that while Wegovy and Zepbound are FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, similar medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved only for type 2 diabetes management

Two enzymes in one

This is why many doctors describe tirzepatide as "GLP-1 plus" it offers the benefits of semaglutide while adding another mechanism to enhance results